Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
2023-05-03 13:51:49 ET Bausch Health Companies ( NYSE: BHC ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open. The consensus EPS Estimate is $0.68 (+457.9% Y/Y) and the consensus Revenue Estimate is $1.95B (+1.6% Y/Y). Over the last...
RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across Canada Canada NewsWire New treatment from Bausch Health, Canada indicated to treat seasonal allergy and associated ocular symptoms in ad...
2023-05-01 09:33:13 ET The U.S. Food and Drug Administration (FDA) accepted Bausch Health Companies' ( NYSE: BHC ) application seeking approval of IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) gel to treat acne vulgaris. The FDA is expected to mak...
PDUFA Action Date is October 20, 2023 LAVAL, QC / ACCESSWIRE / May 1, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for in...
Program Seeks to Increase the Number of People Screened to Help Prevent Colorectal Cancer Diagnoses in Philadelphia LAVAL, QC / ACCESSWIRE / April 24, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced a partnersh...
LAVAL, QC / ACCESSWIRE / April 13, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its first-quarter financial results on Thursday, May 4, 2023. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EDT to discuss the results and provide a business upd...
Salix Pharmaceuticals Releases Third Annual Patient Perspectives Report LAVAL, QC / ACCESSWIRE / April 4, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced the results from the third edition of its patient p...
2023-03-09 23:03:35 ET Summary Carl Icahn’s 13F portfolio value increased from $21.23B to $21.75B this quarter. They decreased Cheniere Energy substantially this quarter. Icahn Enterprises, CVR Energy, and FirstEnergy are the three largest positions. This arti...
2023-03-06 12:30:00 ET Most biotech stocks have low visibility with investors because the risks are pretty high. Nonetheless, the TSX has several names worth watching in 2023. Bausch Health ( TSX:BHC ) has appreciated substantially from year-end 2022, and three more could break ...
LAVAL, QC / ACCESSWIRE / March 1, 2023 / Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company's Board of Directors, effective as of the upcoming 2023 annual meeting of shareholders of the Company. Follow...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT). Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. JJ has over 25 ...
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...
The S&P 500 rose to a new high on Friday, putting the broad-market index on track for yet another weekly gain during the holiday-shortened trading week. The tech-heavy NASDAQ Composite also hit a new high. The Dow Jones Industrials climbed 67.87 points to end Friday at 39,375.87. The ...